Jeri L. Weigand is currently a corporate auditor, (with a clinical focus) working for Medtronic in Fridley, Minnesota. She previously spent thirty years working for 3M Pharmaceuticals in various capacities, most recently, working as an auditor for 3M Pharmaceuticals in St. Paul, MN, conducting audits in the area of Good Clinical Practices (GCP), Good Laboratory Practices (GLP) and Good Manufacturing Practice (GMP). She is a Certified Quality Auditor through the American Society for Quality (ASQ) and a Certified Clinical Research Professional through the Society of Clinical Research Professionals (SOCRA).

Jeri has also worked in the clinical trial materials arena and as a compliance coordinator in the areas of compliance monitoring, cGMP/SOP training, and development and implementation of a division-wide GMP training program, SOP system, calibration system, and laboratory glassware labeling system for the development and analytical groups of 3M Pharmaceuticals.

Weigand is the founder and past chair of the Midwest Clinical Supply Discussion Group, past chair and member of the ISPE Clinical Materials Advisory Group (International Society of Pharmaceutical Engineering), and current member of the ISPE Training Advisory committee. She has been a workshop coordinator and leader for many national meetings and has co-authored a Pre-NDA Approval Inspection Checklist, a paper on Definitions and Controls for Labeling of Clinical Trial Materials and Clinical Supply Operations and the first edition of the Clinical Trial Materials Training Guide. Jeri has also authored a chapter on Training of Clinical Trial Material Personnel for the Second addition of the Drug Products in Clinical Trials.

Jeri has a BS in education from Northwest Missouri State University, Maryville, MO and a Masters in Organizational Leadership from The College of St. Catherine, St. Paul, MN.